Medtronic Acquires Contego Medical for $380 Million to Bolster Stroke Prevention Offerings
Medtronic, based in Minneapolis-St. Paul, is acquiring Contego Medical for $380 million to expand its stroke-prevention product line.

Minneapolis St. Paul, MN, November 16, 2026 — Medtronic, a global leader in medical technology headquartered in the Minneapolis-St. Paul metropolitan area, has announced its intent to acquire Contego Medical. The transaction is valued at $380 million.
The acquisition aims to enhance Medtronic’s existing portfolio of products designed for the prevention of strokes. Contego Medical is known for its development of interventional devices used in neurovascular procedures.
Financial details of the deal indicate a total acquisition price of $380 million. The strategic move is expected to broaden Medtronic’s capabilities in the rapidly evolving field of stroke care, offering healthcare providers more comprehensive solutions for patients at risk of or experiencing stroke events.
The full scope of Contego Medical’s product line and its integration into Medtronic’s operations are anticipated to be detailed following the completion of the acquisition. The company stated that the primary objective is to leverage Contego Medical’s technology to further advance stroke prevention methods.
Story summarized from the original created by Google News on news.google.com, see more information here.